Current status of bare and drug-eluting stents in infrainguinal peripheral vascular disease

Expert Review of Cardiovascular Therapy
Jörg Schmehl, Gunnar Tepe

Abstract

Currently, the use of endovascular therapies including stent application is increasingly becoming the treatment of choice for superficial femoral and below-the-knee lesions. Primary stenting of even longer lesions is supported by favorable results of mid- to long-term evaluations. However, issues such as the long-term patency of these devices, optimal design of the stents used, and the role of coating with drugs for infrainguinal disease are under investigation. With more widespread use, problems such as fractures become evident and further developments will have to address these issues. Currently, a number of studies are being conducted, which will help to clarify the role of patient and lesion selection, choice of device, design of the stent and the question of whether or not to use drug-eluting stents for this application. Furthermore, endovascular therapy of below-the-knee lesions is becoming an increasingly interesting area for interventional procedures.

References

Feb 24, 2001·Journal of Vascular and Interventional Radiology : JVIR·M CejnaJ Lammer
Aug 7, 2001·Journal of Vascular and Interventional Radiology : JVIR·J GrimmM Heller
Sep 12, 2002·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Hannes BalmerIris Baumgartner
Mar 13, 2003·Journal of Vascular and Interventional Radiology : JVIR·Richard R SaxonDonald J Ponec
May 7, 2003·Circulation·J Eduardo SousaMarco A Costa
Apr 9, 2004·Techniques in Vascular and Interventional Radiology·Mark W Mewissen
Sep 4, 2004·RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin·L GrenacherG M Richter
Dec 25, 2004·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Hans KrankenbergThilo Tübler
Jan 18, 2005·Journal of the American College of Cardiology·Dierk ScheinertAndrej Schmidt
Feb 3, 2005·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Patrick PeetersBernd Heublein
Feb 3, 2005·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Schila SabetiMartin Schillinger
Mar 11, 2005·Journal of Vascular and Interventional Radiology : JVIR·Stephan H DudaJean P Bérégi
Apr 13, 2005·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Benjamin WiesingerStephan H Duda
Dec 21, 2005·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Oliver SchlagerMartin Schillinger
Dec 21, 2005·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Dimitris SiablisJohn Tsolakis
May 5, 2006·The New England Journal of Medicine·Martin SchillingerErich Minar
Jun 21, 2006·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Matthias FischerKarl-Ludwig Schulte
Aug 9, 2006·The American Journal of Cardiology·Yoshihiro TsuchiyaEberhard Grube
Oct 14, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Philippe CommeauPierre O Roquebert
Nov 15, 2006·The New England Journal of Medicine·Bruno SchellerUlrich Speck
Dec 2, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·John A OrmistonGuy Armstrong
Dec 13, 2006·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Stephan H DudaJean-Paul Beregi
May 9, 2007·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Dimitris SiablisJohn Tsolakis
Jun 5, 2007·Lancet·Raimund ErbelUNKNOWN PROGRESS-AMS (Clinical Performance and Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators
Jun 15, 2007·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Michael JaffTony Yoder

❮ Previous
Next ❯

Citations

Feb 15, 2011·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Yvonne BausbackAndrej Schmidt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.